Clover Health Investments Corp. Hits New 52-Week High of $5.14

Clover Health Investments Corp. has reached a significant milestone by hitting a new 52-week high of USD 5.14 on June 10, 2026. This achievement marks a notable increase from its 52-week low of USD 1.58, reflecting a substantial upward trend in the stock's performance over the past year. The company operates within the insurance industry and holds a market capitalization of approximately USD 971 million, categorizing it as a small-cap stock. Despite its recent price surge, Clover Health remains in a loss-making position, with a return on equity of -27.71%. The stock's price-to-book ratio stands at 3.15, indicating how the market values the company's equity relative to its book value. In the past year, Clover Health's performance has outpaced the S&P 500, with a reported increase of 20.34%. This performance metric highlights the company's relative strength in the market, despite the challenges faced in the broader economic landscape. As Clover Health continues to navigate its operational environment, this new price point may serve as a pivotal moment in its ongoing journey.